Skip to main content
# Title Department Research Member Research Year
31 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2024
32 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2024
33 High Dose Methotrexate Induced Toxicity in Children with Hematological Malignancy: Incidence and Relation to MTX Level Department of Pediatric Oncology norhan hassan mahmoud 2024
34 Analgesic effect of nulbuphine -bupivacaine combination in ultrasound guided Transverses abdominis plane block in patients undergoing major abdominal cancer surgeries. Department of Anesthesia, Intensive care and Pain management Dr. Rania Mohamed Abd-Elemam 2024
35 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2024
36 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Amany Mohammed Abdel Moatamed 2024
37 Analgesic effect of nulbuphine -bupivacaine combination in ultrasound guided Transverses abdominis plane block in patients undergoing major abdominal cancer surgeries. Department of Anesthesia, Intensive care and Pain management اميرة محمد عثمان محمد 2024
38 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2024
39 Measurement and Evaluation of the Impact of a Carbon Fiber Couch in Radiation Oncology Department of Radiotherapy and Nuclear medicine Dr- Mostafa Ahmed Hashem Soliman 2024
40 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Asmaa Mohamed Zahran Omar 2024